English
Beryl Drugs Q3 Results
- BSE: 524606
- NSE: -
- ISIN: INE415H01017
- Sector: Biotechnology & Drugs
BSE
22.25
-0.14 (-0.63%)
-0.14 (-0.63%)Volume641.00
Updated: Thu 4 Dec, 2025 | 13:37:16
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Beryl Drugs Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 5.12 | 5.41 | -5.41% | 7.17 | -28.58% |
| Depreciation/ Amortization | 0.31 | 0.33 | -6.63% | 0.31 | 1.43% |
| Operating Income | 0.19 | 0.20 | -5.92% | 0.45 | -58.43% |
| Net Income | 0.05 | 0.01 | 656.52% | 0.31 | -83.23% |
| Other Operating Expenses Total | 2.36 | 1.90 | 24.12% | 3.11 | -24.30% |
| Net Income Before Taxes | 0.16 | 0.11 | 49.03% | 0.38 | -57.34% |
| Total Revenue | 5.31 | 5.61 | -5.43% | 7.62 | -30.35% |
| Selling/ General/ Admin Expenses Total | 0.62 | 0.50 | 23.70% | 0.55 | 13.57% |
| Diluted Normalized EPS | 0.10 | 0.01 | 635.29% | 0.61 | -83.61% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.